6 completed. 3 Phase 3, 1 Not applicable, 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 3 |
| Not applicable | 1 | Completed 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 2 | 1 | Completed 1 |
Follow Exendin-9,39: new trials by email Literature Review of Exendin-9,39 trials Research Report on Exendin-9,39
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics Saline, Exendin-9,39, Liraglutide - Healthy | Phase 3 | Completed | Adrian Vella | 21 | 2022-10-17 | 2026-10-28 |
| Endogenous GLP-1 Secretion on Islet Function in People With and Without Type 2 Diabetes Saline, Exendin-9,39, Saline + Intralipid/Heparin - Healthy, Type 2 Diabetes | Phase 3 | Completed | Adrian Vella | 23 | 2021-04-15 | 2023-12-26 |
| A Dose-response Study Examining the Contribution of GLP-1 Receptor Signaling to Glucagon-stimulated Insulin Secretion Exendin-9,39, Saline - Healthy | Phase 3 | Completed | Adrian Vella | 11 | 2021-03-04 | 2023-06-09 |
| Exendin-9,39 and Satiety After Bariatric Surgery Saline, Exendin-9,39 - Obesity | Not applicable | Completed | Mayo Clinic | 29 | 2016-06-01 | 2020-05-01 |
| The Effect of Bariatric Surgery on Metabolism, the Metabolome and Microbiome in Patients With Type 2 Diabetes Roux-en-Y Gastric Bypass (RYGB), Caloric Restriction, Exendin-9,39 - Type 2 Diabetes Mellitus, Obesity | Phase 2 | Completed | Mayo Clinic | 12 | 2016-03-01 | 2022-05-03 |
| A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake Exendin-9,39, Saline - Obesity, Diabetes | Phase 1 | Completed | Mayo Clinic | 3 | 2014-05-01 | 2019-10-23 |
Obesity (3) · Diabetes Mellitus, Type 2 (2) · Diabetes Mellitus (1) · Weight Loss (1)
Adrian Vella (3) · Mayo Clinic (3)
United States (6)
Adrian Vella, MD (3) · Adrian Vella (2) · Meera Shah, MBChB (1)
R01DK126206 (3), R01DK082396 (1), UL1RR024150 (1)